0001062993-22-014274.txt : 20220603
0001062993-22-014274.hdr.sgml : 20220603
20220603160946
ACCESSION NUMBER: 0001062993-22-014274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenbloom David S.
CENTRAL INDEX KEY: 0001924321
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-04448
FILM NUMBER: 22994446
MAIL ADDRESS:
STREET 1: ONE BAXTER PARKWAY
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BAXTER INTERNATIONAL INC
CENTRAL INDEX KEY: 0000010456
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 360781620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BAXTER PKWY
STREET 2: DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
BUSINESS PHONE: 8479482000
MAIL ADDRESS:
STREET 1: ONE BAXTER PARKWAY
STREET 2: DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
FORMER COMPANY:
FORMER CONFORMED NAME: BAXTER TRAVENOL LABORATORIES INC
DATE OF NAME CHANGE: 19880522
FORMER COMPANY:
FORMER CONFORMED NAME: BAXTER LABORATORIES INC
DATE OF NAME CHANGE: 19760608
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-06-01
0000010456
BAXTER INTERNATIONAL INC
BAX
0001924321
Rosenbloom David S.
ONE BAXTER PARKWAY
DEERFIELD
IL
60015
0
1
0
0
SVP and General Counsel
Common Stock, $1 par value
2022-06-01
4
A
0
33940
0
A
33940
D
Common Stock, $1 par value
2022-06-01
4
A
0
7636
0
A
41576
D
Stock Option (Right to Buy)
74.47
2022-06-01
4
A
0
33442
0
A
2032-06-01
Common Stock, $1 par value
33442
33442
D
The reporting person received a grant of 33,940 restricted stock units which are scheduled to vest on June 2, 2025, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan (BII Incentive Plan).
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on June 1, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the BII Incentive Plan.
The options become exercisable in three equal annual installments beginning on June 1, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the BII Incentive Plan.
/s/ Matthew Rice, as attorney in-fact for David S. Rosenbloom
2022-06-03
EX-24
2
exhibit24.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Ellen K. Bradford and Matthew Rice
signing singly, the undersigned's true and lawful attorney in fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of Baxter
International Inc., or any of its direct or indirect subsidiaries (Baxter)
Forms 4 and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder and Form 144 under
Rule 144 under the Securities Act of 1933;
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute
any such Form 4, 5, or 144 and complete and execute any amendment or
amendments thereto, and timely file any such form with the United States
Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney in fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney in fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and
conditions as such attorney in fact may approve in such attorney in
fact's discretion.
The undersigned hereby grants to each such attorney in fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney in fact, or such attorney in fact's
substitute or substitutes, shall lawfully do or cause or have caused
to be done by virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges that the foregoing
attorneys in fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is Baxter assuming, any of the
undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934 and Rule 144 of the Securities Act
of 1933.
This Power of Attorney shall super cede any power of attorney
previously granted by the undersigned with respect to the subject
matter herein and shall remain in full force and effect until the
undersigned is no longer required to file Forms 4, 5 and 144 with
respect to the undersigned's holdings of, and transactions in,
securities issued by Baxter, unless earlier revoked by the
undersigned in a signed document delivered to Baxter.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 18th day of April, 2022.
/s/ David S. Rosenbloom